IWT score for predicting cardiac amyloidosis in patients with hypertensive heart disease
Yuna Matsumoto1, Naoko Ichikawa2,3, Yuina Matsuzawa1
1Clinical Laboratory, St. Luke's International Hospital, Tokyo, Japan.
Insights
Half of patients with Hypertensive Heart Disease (HHD) show increased wall thickness (IWT) scores suggesting cardiac amyloidosis (CA). This study identifies key echocardiographic factors influencing these scores in HHD patients.
Area of Science:
- Cardiology
- Medical Imaging
- Diagnostic Echocardiography
Background:
- Early detection of cardiac amyloidosis (CA) is vital for improving patient prognosis due to recent therapeutic advancements.
- Increased wall thickness (IWT) scoring, proposed in 2020, aids echocardiographic evaluation for CA.
- A significant portion of CA patients are initially diagnosed with other cardiomyopathies, like Hypertensive Heart Disease (HHD).
Purpose of the Study:
- To investigate characteristic IWT score patterns in patients diagnosed with Hypertensive Heart Disease (HHD).
- To assess the controversy surrounding the use of IWT scores for all patients with left ventricular wall thickening.
- To identify factors influencing IWT score classification in HHD patients with suspected CA.
Main Methods:
- Echocardiographic assessment of patients with HHD between August and November 2024.
- Calculation of IWT scores using transthoracic echocardiography.
- Logistic regression analysis of mild left ventricular hypertrophy (LVH) cases with IWT scores between 2 and 7 (gray zone) to identify influencing parameters.
Main Results:
- Out of 121 HHD patients, 51% fell into the suspected CA gray zone based on IWT scores.
- Systolic apex-to-base ratio (SAB), relative wall thickness (RWT), and TAPSE significantly influenced IWT scores.
- Modifications to SAB formula and TAPSE cutoff (17 mm) reduced gray zone cases to 29%.
Conclusions:
- Approximately half of Hypertensive Heart Disease patients exhibit IWT scores that overlap with those suggestive of cardiac amyloidosis.
- Key echocardiographic parameters like SAB, RWT, and TAPSE are crucial for differentiating HHD from CA in borderline cases.
- Refining IWT scoring criteria can improve diagnostic accuracy and reduce misclassification in HHD patients.
Purpose:
Early detection and treatment of cardiac amyloidosis (CA) are essential to improve prognosis, following recent therapeutic advances. Therefore, echocardiographic evaluation is crucial, and an increased wall thickness (IWT) score was proposed in 2020. 35% of patients with CA were previously diagnosed with other cardiomyopathies, such as Hypertensive Heart Disease (HHD). However, using the IWT score for all patients with left ventricular wall thickening remains controversial. In this study, we investigated characteristic IWT score patterns in patients with HHD.
Methods:
We assessed patients with HHD who underwent echocardiography between August and November 2024. IWT scores were calculated using transthoracic echocardiography. Two groups were compared: mild and moderate-to-severe left ventricular hypertrophy (LVH). Logistic regression analysis was conducted for mild LVH cases with IWT scores between 2 and 7 points (suspected CA, gray zone) to analyze parameters that influenced this classification.
Results:
Among 121 patients (mean age: 60.3 ± 11.5 years), 84 (69%), 23 (19%), and 14 (12%) had mild, moderate and severe LVH, respectively. Sixty-two (51%) patients fell into the gray zone. Significant factors affecting IWT score included the systolic apex-to-base ratio (SAB) (Odds ratio [OR] = 42.4, p < 0.001), relative wall thickness (RWT) (OR = 5.0, p = 0.022), and tricuspid annular plane systolic excursion (TAPSE) (OR = 22.5, p < 0.001). Modifying the SAB formula and establishing a TAPSE cutoff value of 17 mm decreased the number of gray zone cases to 35 (29%).
Conclusion:
Half of the patients with HHD demonstrated IWT scores consistent with suspected CA.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Acute Coronary Syndrome III: Diagnostic Studies
Heart Failure I: Introduction
Heart Failure IV: Classification and Diagnostic Evaluation


